Press Releases Arcellx, Inc.

Equities

ACLX

US03940C1009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
53.62 ^USD	+1.57%		+1.69%	-3.39%

May. 15	Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating	MT
May. 14	Evercore ISI Starts Arcellx With Outperform Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arcellx : IMMagine-3 Multi-center, Global, Phase 3 Randomized Control Clinical Trial Design	May. 09	PU
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	May. 09	BU
Arcellx Provides First Quarter 2024 Financial Results	May. 09	BU
Arcellx to Participate in Two Upcoming Investor Conferences	May. 07	BU
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 04	BU
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	Mar. 20	BU
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference	Feb. 29	PR
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights	Feb. 28	PR
Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH	Dec. 11	AQ
Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition	Nov. 03	AQ
Arcellx : November 2023 Corporate Presentation	Nov. 01	PU
Arcellx to Participate in Two Upcoming Investor Conferences	23-10-26	PR
Arcellx : September 2023 Corporate Presentation	23-09-01	PU
Arcellx : August 2023 Corporate Presentation	23-08-15	PU
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results	23-08-14	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	23-07-17	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	23-07-12	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	23-07-03	PR
Arcellx : Corporate Presentation July 2023	23-06-29	PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	23-06-23	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Arcellx, Inc.

Equities

ACLX

US03940C1009

Press Releases

Filters